Rituximab in Membranous Nephropathy: Not All Studies Are Created Equal

Publisher： Karger

E-ISSN： 2235-3186|135|1|46-50

ISSN： 1660-8151

Source： Nephron, Vol.135, Iss.1, 2016-09, pp. : 46-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab Treatment for Membranous Nephropathy: A French Clinical and Serological Retrospective Study of 28 Patients

By  

Nephron Extra, Vol. 1, Iss. 1, 2011-12 ,pp. : 251-261

Karger

Access to resources Recommend Favorite

A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)

By  

Nephron, Vol. 130, Iss. 3, 2015-06 ,pp. : 159-168

Karger

Access to resources Recommend Favorite

Management of Membranous Nephropathy in Asia

By  

Kidney Diseases, Vol. 1, Iss. 2, 2015-09 ,pp. : 119-125

Karger

Access to resources Recommend Favorite

Relapsing Membranous Nephropathy

By  

American Journal of Nephrology, Vol. 19, Iss. 4, 1999-08 ,pp. : 474-479

Karger

Access to resources Recommend Favorite

Pleural Mesothelioma and Membranous Nephropathy

By  

Nephron, Vol. 84, Iss. 1, 2000-01 ,pp. : 71-74

Karger

Access to resources Recommend Favorite